Vital Fluids: Proposal Rejuvenates China Biologics
On the 19 June last year, CITIC Capital Holdings made an unsolicited, preliminary non-binding proposal for China Biologic Products (CBPO US) - a...
621 Views
China Blood Products: Deals Highlight Values
Grifols SA (GRF SM) and Shanghai RAAS Blood Products Co Ltd (002252.SZ) recently announced an asset exchange that effectively combines the...
657 Views